{"id":"placebos-morning","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events attributed to placebo)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos work primarily through the placebo effect, wherein patient expectations and belief in treatment activate neural pathways that can modulate pain perception, immune function, and symptom severity. The effect is enhanced by clinical context, provider interaction, and ritualistic elements of treatment administration. Placebos are commonly used as control comparators in clinical trials to isolate the true pharmacological efficacy of active drugs.","oneSentence":"Placebos are inert substances that produce therapeutic effects through psychobiological mechanisms including expectation, conditioning, and natural disease course.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:29:10.020Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in phase 3 clinical trials"}]},"trialDetails":[{"nctId":"NCT07494279","phase":"NA","title":"Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2026-03-30","conditions":"Prehypertension, Hypertension","enrollment":106},{"nctId":"NCT07072468","phase":"PHASE2","title":"Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)","status":"RECRUITING","sponsor":"VM Therapeutics LLC","startDate":"2025-12-12","conditions":"Chemotherapy-induced Peripheral Neuropathy, Drug-Induced Nephropathy","enrollment":16},{"nctId":"NCT05142735","phase":"NA","title":"Effects of NAC on Symptoms of CHR Patients","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-01-13","conditions":"Prodromal Schizophrenia","enrollment":90},{"nctId":"NCT07496034","phase":"PHASE3","title":"Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine: A Double-Blind Randomized Controlled Trial","status":"RECRUITING","sponsor":"Tsai, Chueh-Yi, MD","startDate":"2025-07-01","conditions":"Episodic Migraine","enrollment":40},{"nctId":"NCT07050316","phase":"PHASE1","title":"Intranasal Administration of Dodecyl Creatine Ester (CBT101) in Healthy Male Subjects","status":"COMPLETED","sponsor":"Ceres Brain Therapeutics","startDate":"2025-03-14","conditions":"Neurologic Diseases, General","enrollment":48},{"nctId":"NCT07495995","phase":"PHASE2","title":"Single-Center Phase II Double-Blind Trial of SAMe to Prevent Liver Cancer in MASLD-Related Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-04-15","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","enrollment":94},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT07264192","phase":"PHASE1","title":"A Study of HS-10518 in Healthy Adult Premenopausal Females in China","status":"COMPLETED","sponsor":"West China Second University Hospital","startDate":"2025-03-11","conditions":"Infertility, Female","enrollment":60},{"nctId":"NCT07236190","phase":"PHASE1, PHASE2","title":"Biomarker-based Trial of NPC-1 for Alzheimer's Pathology","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03","conditions":"Alzheimer Disease, Mild Cognitive Impairment (MCI), Subjective Cognitive Complaints (SCCs)","enrollment":40},{"nctId":"NCT07487831","phase":"PHASE4","title":"The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03-16","conditions":"Atopic Dermatitis (Eczema), Psoriasis","enrollment":50},{"nctId":"NCT05815602","phase":"PHASE3","title":"Ebastine Versus Mebeverine in IBS Patients","status":"RECRUITING","sponsor":"Guy Boeckxstaens","startDate":"2023-03-30","conditions":"IBS - Irritable Bowel Syndrome, IBS","enrollment":200},{"nctId":"NCT07393360","phase":"NA","title":"Effect of a Food for Special Medical Purposes on Muscle Mass Preservation During GLP-1 RAs Weight Loss Treatment","status":"RECRUITING","sponsor":"Pharmanutra S.p.a.","startDate":"2025-12-11","conditions":"Obesity & Overweight","enrollment":144},{"nctId":"NCT04781543","phase":"PHASE2","title":"A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis","status":"TERMINATED","sponsor":"Amgen","startDate":"2021-11-05","conditions":"Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic","enrollment":301},{"nctId":"NCT06512389","phase":"PHASE2","title":"Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-08-16","conditions":"Alcohol Use Disorder","enrollment":36},{"nctId":"NCT06994715","phase":"NA","title":"Effects of Acupressure Applied to Intensive Care Patients on Physiological Parameters, Pain, Sleep Quality, Anxiety and Perception of Nursing Presence","status":"COMPLETED","sponsor":"Gazi University","startDate":"2025-05-01","conditions":"Acupressure, Intensive Care Unit, Anxiety","enrollment":60},{"nctId":"NCT04675788","phase":"PHASE4","title":"Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening","status":"COMPLETED","sponsor":"Indiana University","startDate":"2021-09-02","conditions":"Long QT Syndrome, Abnormalities, Drug-Induced","enrollment":73},{"nctId":"NCT01577082","phase":"PHASE3","title":"Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-04-20","conditions":"Asthma","enrollment":542},{"nctId":"NCT05529927","phase":"PHASE2","title":"Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder","status":"NOT_YET_RECRUITING","sponsor":"Parnassia Addiction Research Centre","startDate":"2026-05","conditions":"Cocaine Use Disorder","enrollment":204},{"nctId":"NCT07480668","phase":"NA","title":"Aromatherapy for Mental Health Promotion in IVF Patients","status":"RECRUITING","sponsor":"Federal University of Minas Gerais","startDate":"2026-03","conditions":"Anxiety, Stress, Depression Disorder","enrollment":120},{"nctId":"NCT07478328","phase":"PHASE2","title":"Chaigui Longmu Ejiao Paste for Ischemic Heart Disease","status":"NOT_YET_RECRUITING","sponsor":"Longhua Hospital","startDate":"2026-03-08","conditions":"Ischemic Heart Disease","enrollment":60},{"nctId":"NCT06366464","phase":"PHASE3","title":"A Study of Pitolisant in Patients With Prader-Willi Syndrome","status":"RECRUITING","sponsor":"Harmony Biosciences Management, Inc.","startDate":"2024-05-28","conditions":"Prader-Willi Syndrome","enrollment":134},{"nctId":"NCT05325502","phase":"NA","title":"Does Caffeine Facilitate Human Reward Learning Behaviors?","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yu-Shiuan Lin","startDate":"2022-05-05","conditions":"Caffeine","enrollment":36},{"nctId":"NCT07447063","phase":"PHASE4","title":"The Impact of Dietary Salt on the Severity of Eczema","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-03-06","conditions":"Eczema, Atopic Dermatitis","enrollment":40},{"nctId":"NCT07478744","phase":"PHASE2","title":"A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Disorder","status":"NOT_YET_RECRUITING","sponsor":"Synendos Therapeutics AG","startDate":"2026-04","conditions":"Generalized Anxiety Disorder","enrollment":24},{"nctId":"NCT07466732","phase":"EARLY_PHASE1","title":"Effects of Caffeine Ingestion on Morning Cognitive and Muscle Repeated Sprint Performance in Males","status":"ENROLLING_BY_INVITATION","sponsor":"Liverpool John Moores University","startDate":"2025-12-08","conditions":"Caffeine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT06708299","phase":"PHASE3","title":"CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)","status":"RECRUITING","sponsor":"Cardiol Therapeutics Inc.","startDate":"2025-04-07","conditions":"Recurrent Pericarditis","enrollment":110},{"nctId":"NCT07469852","phase":"PHASE1, PHASE2","title":"Effects of Caffeine Ingestion on Morning Cognitive and 4-km Time Trial Performance in Males","status":"ACTIVE_NOT_RECRUITING","sponsor":"Liverpool John Moores University","startDate":"2026-01-12","conditions":"Caffeine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT07466628","phase":"PHASE4","title":"Effects of Caffeine Ingestion on Morning Cognitive and Muscle Strength Measures in Males","status":"COMPLETED","sponsor":"Liverpool John Moores University","startDate":"2024-11-15","conditions":"Caffine, Placebo - Control, No Pill","enrollment":15},{"nctId":"NCT06322212","phase":"EARLY_PHASE1","title":"Type 2 Diabetes and Blood Brain Barrier Improvement","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2024-08-01","conditions":"Type2diabetes","enrollment":52},{"nctId":"NCT07468526","phase":"PHASE3","title":"An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria","status":"NOT_YET_RECRUITING","sponsor":"Menzies School of Health Research","startDate":"2026-06-01","conditions":"Malaria","enrollment":1019},{"nctId":"NCT07461194","phase":"NA","title":"Timing of Broccoli Sprout Intake to Improve Exercise Performance","status":"NOT_YET_RECRUITING","sponsor":"The Swedish School of Sport and Health Sciences","startDate":"2026-03-31","conditions":"Physical Performance, Glucose, Glycogen Metabolism","enrollment":30},{"nctId":"NCT03179631","phase":"PHASE3","title":"Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy","status":"COMPLETED","sponsor":"PTC Therapeutics","startDate":"2017-07-06","conditions":"Muscular Dystrophy, Duchenne, Muscular Dystrophies, Muscular Disorders, Atrophic","enrollment":360},{"nctId":"NCT07462715","phase":"PHASE4","title":"Statins Against Bushfire Smoke","status":"NOT_YET_RECRUITING","sponsor":"Menzies Institute for Medical Research","startDate":"2026-05-01","conditions":"Healthy Adults","enrollment":100},{"nctId":"NCT07404449","phase":"PHASE1","title":"Sex-Speciffic Longevity Food Supplements","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Primorska","startDate":"2026-03-07","conditions":"Aging","enrollment":60},{"nctId":"NCT06931977","phase":"NA","title":"Natural Product System and Lifestyle Modification","status":"COMPLETED","sponsor":"dōTERRA International","startDate":"2025-04-29","conditions":"Healthy","enrollment":97},{"nctId":"NCT07454525","phase":"NA","title":"Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.","status":"NOT_YET_RECRUITING","sponsor":"AB Biotics, SA","startDate":"2026-02","conditions":"Skin, Skin Microbiome, Skin Microbiota","enrollment":45},{"nctId":"NCT06444763","phase":"PHASE3","title":"Effect of Maolactin™ FMR on Exercise Recovery, Inflammation and Muscle Comfort in an Otherwise Healthy Population","status":"COMPLETED","sponsor":"RDC Clinical Pty Ltd","startDate":"2025-02-27","conditions":"Chronic Inflammation, Mobility, Muscle Pain","enrollment":97},{"nctId":"NCT07441395","phase":"PHASE2","title":"Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD","status":"RECRUITING","sponsor":"Corvus Pharmaceuticals, Inc.","startDate":"2026-02","conditions":"Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema","enrollment":200},{"nctId":"NCT07080931","phase":"PHASE3","title":"Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia","status":"RECRUITING","sponsor":"Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.","startDate":"2025-02-24","conditions":"Androgenetic Alopecia","enrollment":294},{"nctId":"NCT06747468","phase":"PHASE3","title":"Avexitide for Treatment of Post-Bariatric Hypoglycemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amylyx Pharmaceuticals Inc.","startDate":"2025-04-29","conditions":"Post Bariatric Hypoglycemia","enrollment":75},{"nctId":"NCT07450482","phase":"PHASE2","title":"Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPD","status":"COMPLETED","sponsor":"Joincare Pharmaceutical Group Industry Co., Ltd","startDate":"2025-07-22","conditions":"COPD (Chronic Obstructive Pulmonary Disease), COPD","enrollment":42},{"nctId":"NCT07446361","phase":"NA","title":"A Study to Evaluate the Efficacy of Collagen 16 Serum Alone, Against and as an Adjunct to Radiesse® Biostimulation Procedure in Female Trial Participants With Aged Skin","status":"NOT_YET_RECRUITING","sponsor":"Vichy Laboratoires","startDate":"2026-03-01","conditions":"Wrinkle Appearance, Skin Quality","enrollment":180},{"nctId":"NCT07441096","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-20","conditions":"Premenstrual Syndrome, Women Health","enrollment":60},{"nctId":"NCT07441070","phase":"NA","title":"Effect of Ashwagandha Root Extract on Stress, Anxiety, and Sleep Quality in Adults Experiencing Minority Stress","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-24","conditions":"Minority Stress, Psychological Stress, Anxiety","enrollment":80},{"nctId":"NCT06016842","phase":"PHASE3","title":"A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis","status":"RECRUITING","sponsor":"Ipsen","startDate":"2023-08-31","conditions":"Primary Biliary Cholangitis (PBC)","enrollment":276},{"nctId":"NCT05869812","phase":"PHASE2","title":"Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-05-29","conditions":"Atrophy","enrollment":30},{"nctId":"NCT06383403","phase":"PHASE3","title":"A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ipsen","startDate":"2024-07-09","conditions":"Primary Biliary Cholangitis","enrollment":69},{"nctId":"NCT04526665","phase":"PHASE3","title":"Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ipsen","startDate":"2020-09-24","conditions":"Primary Biliary Cirrhosis","enrollment":161},{"nctId":"NCT07401212","phase":"NA","title":"GUTLINK4KIDS Intervention","status":"RECRUITING","sponsor":"University of Reading","startDate":"2026-03-02","conditions":"Temperament, Sleep, Cognition","enrollment":106},{"nctId":"NCT06306183","phase":"NA","title":"Effect of Vitamin C on Pain Reduction After an Emergency Department Visit","status":"RECRUITING","sponsor":"Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal","startDate":"2025-09-01","conditions":"Pain, Acute","enrollment":204},{"nctId":"NCT07439601","phase":"NA","title":"Long-Term Omega-3 and Omega-3 Index >8%: Effects on Physiological Recovery","status":"NOT_YET_RECRUITING","sponsor":"St. Mary's University, Twickenham","startDate":"2026-02-28","conditions":"Focus on Omega 3 Index on Recovery","enrollment":46},{"nctId":"NCT06273540","phase":"PHASE1","title":"Phase1, STP7 Cocaine Drug-Drug Interaction Study","status":"COMPLETED","sponsor":"Stalicla SA","startDate":"2024-04-15","conditions":"Cocaine Use Disorder","enrollment":21},{"nctId":"NCT06969287","phase":"PHASE3","title":"Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-03-07","conditions":"Delirium, Surgery-Complications","enrollment":46},{"nctId":"NCT07322003","phase":"PHASE3","title":"Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS","status":"RECRUITING","sponsor":"Prilenia","startDate":"2026-02-01","conditions":"Amyotrophic Lateral Sclerosis","enrollment":500},{"nctId":"NCT03630328","phase":"NA","title":"Angelica Gigas Dietary Supplements and Human Immune Cells","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2019-02-06","conditions":"Innate Immune Cells","enrollment":15},{"nctId":"NCT05855746","phase":"PHASE3","title":"Colchicine Versus Placebo in Acute Myocarditis Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-07-16","conditions":"Acute Myocarditis","enrollment":300},{"nctId":"NCT07433062","phase":"PHASE1","title":"A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-14","conditions":"Type 2 Diabetes Mellitus","enrollment":28},{"nctId":"NCT06409949","phase":"NA","title":"MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology","status":"RECRUITING","sponsor":"University of Nebraska","startDate":"2023-06-01","conditions":"Peripheral Arterial Disease","enrollment":60},{"nctId":"NCT06223360","phase":"PHASE2","title":"A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)","status":"RECRUITING","sponsor":"Alzheimer's Disease Cooperative Study (ADCS)","startDate":"2024-03-28","conditions":"Alzheimer Disease","enrollment":406},{"nctId":"NCT03878589","phase":"PHASE2, PHASE3","title":"Understanding Cognition, Oxytocin & Pain in Elders","status":"COMPLETED","sponsor":"University of Florida","startDate":"2019-08-06","conditions":"Knee Osteoarthritis, Osteoarthritis","enrollment":83},{"nctId":"NCT05134441","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Immunic AG","startDate":"2021-11-18","conditions":"Multiple Sclerosis","enrollment":1121},{"nctId":"NCT05201638","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Immunic AG","startDate":"2022-01-12","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":1100},{"nctId":"NCT07424677","phase":"PHASE3","title":"Study of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy","status":"NOT_YET_RECRUITING","sponsor":"Zydus Therapeutics Inc.","startDate":"2026-03","conditions":"Primary Biliary Cholangitis","enrollment":89},{"nctId":"NCT04257929","phase":"PHASE2","title":"A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harmony Biosciences Management, Inc.","startDate":"2020-12-09","conditions":"Prader-Willi Syndrome","enrollment":65},{"nctId":"NCT07422103","phase":"NA","title":"PAN-CLO-BU (PANcreas-CLOstridium-BUtyricum)","status":"NOT_YET_RECRUITING","sponsor":"Casa di Cura Dott. Pederzoli","startDate":"2026-03-15","conditions":"Pancreatic Cancer, Pancreatic Diseases, Gastrointestinal Symptoms","enrollment":158},{"nctId":"NCT07420985","phase":"PHASE2","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of the Ingavirin Forte Capsules (Valenta Pharm JSC) at Different Doses in Subjects With Influenza and Other Acute Respiratory Viral Infections.","status":"RECRUITING","sponsor":"Valenta Pharm JSC","startDate":"2025-10-24","conditions":"Influenza, Acute Respiratory Viral Infection","enrollment":300},{"nctId":"NCT06125951","phase":"PHASE2, PHASE3","title":"Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Actinogen Medical","startDate":"2024-04-12","conditions":"Dementia Moderate, Dementia, Mild, Alzheimer Disease","enrollment":247},{"nctId":"NCT07216235","phase":"PHASE3","title":"Long-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Zydus Therapeutics Inc.","startDate":"2026-02","conditions":"Primary Biliary Cholangitis","enrollment":386},{"nctId":"NCT04903002","phase":"PHASE2, PHASE3","title":"Evaluating the Efficacy of Intranasal Oxytocin on Chronic Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial University of Newfoundland","startDate":"2022-04-01","conditions":"Chronic Pain","enrollment":336},{"nctId":"NCT07418957","phase":"PHASE3","title":"Efficacy and Safety of Vaginal Lactobacillus Dual Probiotic Capsules in Bacterial Vaginosis","status":"COMPLETED","sponsor":"Guangdong Longchuangji Pharmaceutical Co., Ltd.","startDate":"2024-06-12","conditions":"Bacterial Vaginosis (BV)","enrollment":402},{"nctId":"NCT05540678","phase":"NA","title":"The FibreGum Study - Changing the Course of Obesity in Children","status":"TERMINATED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2022-11-30","conditions":"Nutritional and Metabolic Diseases, Child Obesity, Adolescent Obesity","enrollment":93},{"nctId":"NCT06558071","phase":"PHASE3","title":"Supplementation of Galatonol 300 mg / Striatin 30 mg in Postpartum Lactating Mothers","status":"COMPLETED","sponsor":"Dexa Medica Group","startDate":"2024-10-21","conditions":"Lactation Induced","enrollment":160},{"nctId":"NCT02032823","phase":"PHASE3","title":"Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2014-04-22","conditions":"Breast Cancer","enrollment":1836},{"nctId":"NCT07264517","phase":"PHASE2","title":"Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).","status":"RECRUITING","sponsor":"Instituto Grifols, S.A.","startDate":"2025-11-03","conditions":"Dry Eye Disease","enrollment":100},{"nctId":"NCT07405957","phase":"NA","title":"Effects of Two Different Lion's Mane Extracts (Lions Mane Fruiting Body & Lions Mane Fruiting Body With Mycellium) on Cognitive Performance, Subjective Affect, Serum Biomarkers, and Gut Microbiota in Healthy Adults","status":"COMPLETED","sponsor":"Applied Food Sciences Inc.","startDate":"2025-02-11","conditions":"Healthy Adult Females, Healthy Adult Male","enrollment":87},{"nctId":"NCT07279558","phase":"PHASE2","title":"Cannabidiol and Alcohol Use Disorder Phenotypes","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-02-01","conditions":"Alcohol Use Disorder","enrollment":180},{"nctId":"NCT07411378","phase":"PHASE2","title":"Testing the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.","status":"NOT_YET_RECRUITING","sponsor":"Biophytis","startDate":"2026-07","conditions":"Muscle Wasting, Obesity & Overweight, Obesity","enrollment":164},{"nctId":"NCT07113275","phase":"PHASE3","title":"A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in High-Risk Locally Advanced Rectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"Tao Zhang","startDate":"2026-02-11","conditions":"Rectal Cancer, Total Neoadjuvant Therapy, Radiotherapy","enrollment":435},{"nctId":"NCT07406035","phase":"PHASE2","title":"A Phase II Clinical Trial to Evaluate the Efficacy and Safety of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2026-04","conditions":"Psoriatic Arthritis","enrollment":156},{"nctId":"NCT06024421","phase":"PHASE1","title":"Evaluation of Tolerance and Pharmacokinetic Profile of High Doses of Favipiravir in Healthy Volunteers","status":"RECRUITING","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2024-05-14","conditions":"Infectious Disease, Pharmacology","enrollment":39},{"nctId":"NCT07405632","phase":"NA","title":"The Impact of Supplementation With Hericium Erinaceus (Lion's Mane) Extract on Cognitive Functioning","status":"COMPLETED","sponsor":"University of Social Sciences and Humanities, Warsaw","startDate":"2025-01-13","conditions":"Attention, Memory, Cognitive Function and Well-Being","enrollment":85},{"nctId":"NCT07407634","phase":"EARLY_PHASE1","title":"A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.","status":"NOT_YET_RECRUITING","sponsor":"Xi'an Xintong Pharmaceutical Research Co.,Ltd.","startDate":"2026-03-25","conditions":"Non-Alcoholic Fatty Liver Disease","enrollment":94},{"nctId":"NCT07402694","phase":"PHASE4","title":"Oral Health Outcomes With Amphion Mouthwash as an Adjunct to Non-Surgical Periodontal Therapy","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-03-01","conditions":"Periodontitis, Mouthwash","enrollment":60},{"nctId":"NCT07403942","phase":"NA","title":"The Skin Anti-Aging Effects of Vitamin K2 (MK-7): a Clinical Split-Face/Neck Trial","status":"COMPLETED","sponsor":"Nanjing Ascend Biotech Technology Co., Ltd.","startDate":"2024-12-26","conditions":"Skin Aging of Face and Neck","enrollment":36},{"nctId":"NCT03527472","phase":"PHASE2","title":"Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2018-08-23","conditions":"Lupus Erythematosus, Systemic","enrollment":111},{"nctId":"NCT06215859","phase":"PHASE3","title":"Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy","status":"COMPLETED","sponsor":"Viatris Specialty LLC","startDate":"2023-12-29","conditions":"Acute Pain, Post Operative Pain, Pain","enrollment":579},{"nctId":"NCT07398885","phase":"NA","title":"Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized Trial","status":"COMPLETED","sponsor":"University Tunis El Manar","startDate":"2024-07-01","conditions":"System; Lupus Erythematosus","enrollment":59},{"nctId":"NCT04393675","phase":"PHASE1, PHASE2","title":"Study to Investigate the Safety of LT5001 Drug Product for Uremic Pruritus in Hemodialysis Patients","status":"TERMINATED","sponsor":"Lumosa Therapeutics Co., Ltd.","startDate":"2020-05-14","conditions":"Uremic Pruritus","enrollment":18},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT06987643","phase":"PHASE2","title":"A Clinical Study to Investigate the Effect of Oral Neflamapimod on Motor Recovery After Acute Ischaemic Stroke","status":"RECRUITING","sponsor":"EIP Pharma Inc","startDate":"2025-06-20","conditions":"Moderate to Severe Acute Ischaemic Stroke, Ischaemic Stroke","enrollment":90},{"nctId":"NCT07396129","phase":"PHASE1, PHASE2","title":"Assessing the Efficacy of a High-Dose Lidocaine-Tetracaine Cream for the Treatment of Peripheral Neuropathic Pain","status":"NOT_YET_RECRUITING","sponsor":"Pontificia Universidad Catolica de Chile","startDate":"2026-01-12","conditions":"Neuropathic Chronic Pain","enrollment":30},{"nctId":"NCT04845347","phase":"NA","title":"A Wearable Morning Light Treatment for Postpartum Depression","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-06-23","conditions":"Post Partum Depression","enrollment":95},{"nctId":"NCT07392723","phase":"PHASE2","title":"ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults","status":"RECRUITING","sponsor":"Michal Schnaider Beeri, Ph.D.","startDate":"2025-01-12","conditions":"Cognitive Dysfunction, Alzheimer Disease, Blood-Brain Barrier","enrollment":20},{"nctId":"NCT02584439","phase":"PHASE3","title":"Effect of Pharmacological Heart Rate Reduction on Visco-elastic Properties of the Arterial Wall (BRADYVASC)","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2015-12-03","conditions":"Healthy, Vascular Stiffness, Aging","enrollment":20},{"nctId":"NCT05746273","phase":"PHASE2","title":"Depressed Mood Improvement Through Nicotine Dosing 3","status":"RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2023-04-15","conditions":"Depressive Disorder","enrollment":60},{"nctId":"NCT07390552","phase":"PHASE2","title":"A Study of PLH-2301 in Subjects With Sarcopenia","status":"NOT_YET_RECRUITING","sponsor":"Pluto Inc.","startDate":"2026-02-23","conditions":"Sarcopenia in Elderly","enrollment":168},{"nctId":"NCT05205811","phase":"PHASE3","title":"The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette","status":"COMPLETED","sponsor":"Rose Research Center, LLC","startDate":"2021-12-14","conditions":"Smoking Cessation","enrollment":180},{"nctId":"NCT07388264","phase":"NA","title":"Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Microbiome Changes","status":"RECRUITING","sponsor":"Lindenwood University","startDate":"2025-06-15","conditions":"Gastrointestinal Symptoms, Constipation, Gut Health","enrollment":30},{"nctId":"NCT07063615","phase":"NA","title":"A Clinical Study to Assess the Safety and Effectiveness of Scalp Cream for Symptom Relief and Microbiome Balance in Mild-moderate Seborrheic Dermatitis Patients.","status":"ACTIVE_NOT_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-07-21","conditions":"Seborrheic Dermatitis","enrollment":34},{"nctId":"NCT02655315","phase":"PHASE2","title":"Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2016-02-09","conditions":"Parkinson Disease","enrollment":372}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4374,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebos morning","genericName":"Placebos morning","companyName":"Basque Health Service","companyId":"basque-health-service","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebos are inert substances that produce therapeutic effects through psychobiological mechanisms including expectation, conditioning, and natural disease course. Used for Control arm in phase 3 clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}